BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1377673)

  • 1. Characterization of prostaglandin (PG)-binding sites expressed on human basophils. Evidence for a prostaglandin E1, I2, and a D2 receptor.
    Virgolini I; Li S; Sillaber C; Majdic O; Sinzinger H; Lechner K; Bettelheim P; Valent P
    J Biol Chem; 1992 Jun; 267(18):12700-8. PubMed ID: 1377673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modified LDL decreases the binding of prostaglandin E2, I2, and E1 onto monocytes in patients with peripheral vascular disease.
    Li SR; Yang Q; Koller E; Kurtaran A; Bischof C; Leimer M; Rauscha F; Pidlich J; Virgolini I
    Arterioscler Thromb Vasc Biol; 1997 Oct; 17(10):2066-73. PubMed ID: 9351373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
    Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
    Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylsalicylic acid (ASA) protects the prostaglandin-cAMP-system of human hypernephroma cells against irradiation-induced alterations.
    Li SR; Yang Q; Wandl E; Pirker W; Virgolini I
    Br J Cancer; 1993 Oct; 68(4):695-701. PubMed ID: 7691143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prostaglandin interaction in the human liver].
    Virgolini I; Weiss K; Hermann M; Müller C; Sinzinger H
    Klin Wochenschr; 1989 Dec; 67(24):1229-35. PubMed ID: 2483738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Separate receptors for prostacyclin and prostaglandin E2 on human gel-filtered platelets.
    Eggerman TL; Andersen NH; Robertson RP
    J Pharmacol Exp Ther; 1986 Mar; 236(3):568-73. PubMed ID: 2869139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional data.
    Sharif NA; Xu SX; Williams GW; Crider JY; Griffin BW; Davis TL
    J Pharmacol Exp Ther; 1998 Aug; 286(2):1094-102. PubMed ID: 9694973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin moieties that determine receptor binding specificity in the bovine corpus luteum.
    Anderson LE; Schultz MK; Wiltbank MC
    J Reprod Fertil; 1999 May; 116(1):133-41. PubMed ID: 10505064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prostaglandin-receptors in human and rat liver: interspecies differences at the prostaglandin receptor-level.
    Virgolini I; Müller C; Hermann M; Schütz W; Sinzinger H
    Prostaglandins; 1988 Dec; 36(6):807-18. PubMed ID: 2469102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of LDL and VLDL binding sites on human basophils and mast cells.
    Virgolini I; Li SR; Yang Q; Koller E; Sperr WR; Leimer M; Angelberger P; Nimpf J; Schneider W; Valent P
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):17-26. PubMed ID: 7538422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PGE2 binding sites and PG-stimulated cyclic AMP accumulation in rat isolated glomeruli and glomerular cultured cells.
    Friedlander G; Chansel D; Sraer J; Bens M; Ardaillou R
    Mol Cell Endocrinol; 1983 May; 30(2):201-14. PubMed ID: 6133804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for distinct prostaglandin I2 and D2 receptors in human platelets.
    Miller OV; Gorman RR
    J Pharmacol Exp Ther; 1979 Jul; 210(1):134-40. PubMed ID: 221643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostaglandin E2 binding sites in human renal tissue: characterization and localization by radioligand binding and autoradiography.
    Eriksson LO; Larsson B; Hedlund H; Andersson KE
    Acta Physiol Scand; 1990 Jul; 139(3):393-404. PubMed ID: 2173350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniques.
    Sharif NA; Davis TL
    J Pharm Pharmacol; 2002 Apr; 54(4):539-47. PubMed ID: 11999132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [3H]iloprost and prostaglandin E2 compete for the same receptor site on cardiac sarcolemmal membranes.
    Lerner RW; Lopaschuk GD; Catena RC; Olley PM
    Biochim Biophys Acta; 1992 Apr; 1105(2):189-92. PubMed ID: 1375098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of prostacyclin receptors in luteinizing hormone-releasing hormone immortalized neurons: role in the control of hormone secretion.
    Pimpinelli F; Rovati GE; Capra V; Piva F; Martini L; Maggi R
    Endocrinology; 1999 Jan; 140(1):171-7. PubMed ID: 9886823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prostaglandin receptors and prostaglandin metabolism in the terminal circulation of the brain].
    Wasinger T
    Wien Klin Wochenschr; 1989 Dec; 101(23):821-4. PubMed ID: 2514495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
    Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
    Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.